Celastrol, in addition to inhibiting MYB’s transcriptional activity, reduced the proliferative capacity of AML cells, induced their differentiation and apoptosis and delayed the development of leukemia in an in vivo mouse model of AML [33]. Here, MYB is linked to acute myeloid leukemia.